Prognostic reclassification and survival outcomes in intermediate- and poor-risk nonseminomatous germ cell tumors (NSGCT)

被引：0
|
作者：
Jobanputra, Kunal Naishadh
Prakash, Gagan
Arora, Amandeep
Jadhav, Bhagyashri
Pal, Mahendra
Pawar, Akash
Dey, Sayak
Bakshi, Ganesh
Murthy, Vedang
Maitre, Priyamvada
Menon, Nandini Sharrel
Shah, Minit Jalan
Menon, Santosh
Popat, Palak
Ringe-Katdare, Aparna
Sable, Nilesh
Agrawal, Archi
Noronha, Vanita
Prabhash, Kumar
Joshi, Amit
机构：
[1] Tata Mem Hosp, Mumbai, India
[2] Homi Bhabha Natl Inst, Tata Mem Ctr, Mumbai, India
[3] Tata Mem Hosp, Tata Mem Ctr, Mumbai, India
[4] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Navi Mumbai, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5033
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ETOPOSIDE, CISPLATIN, BLEOMYCIN, AND CYCLOPHOSPHAMIDE (ECBC) AS 1ST-LINE CHEMOTHERAPY FOR POOR-RISK NONSEMINOMATOUS GERM-CELL TUMORS
    GERL, A
    CLEMM, C
    HENTRICH, M
    HARTENSTEIN, R
    WILMANNS, W
    ACTA ONCOLOGICA, 1993, 32 (05) : 541 - 546
  • [32] CARBOPLATIN, ETOPOSIDE, AND BLEOMYCIN FOR PATIENTS WITH POOR-RISK GERM-CELL TUMORS
    MOTZER, RJ
    COOPER, K
    GELLER, NL
    PFISTER, DG
    LIN, SY
    BAJORIN, D
    SCHER, HI
    HERR, H
    FAIR, W
    MORSE, M
    SOGANI, P
    WHITMORE, W
    BOSL, GJ
    CANCER, 1990, 65 (11) : 2465 - 2470
  • [33] Outcomes of progression on surveillance for clinical stage I nonseminomatous germ cell tumours (NSGCT)
    Hamilton, Robert James
    Nayan, Madhur
    Anson-Cartwright, Lynn
    Bedard, Philippe L.
    Moore, Malcolm
    Chung, Peter W. M.
    INarde, Padraig Richard
    Sweet, Joan
    O'Malley, Martin
    Atenafu, Eshetu G.
    Jewett, Michael K. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [34] Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
    S D Fosså
    B Paluchowska
    A Horwich
    G Kaiser
    P H M de Mulder
    O Koriakine
    A T van Oosterom
    L de Prijck
    L Collette
    R de Wit
    British Journal of Cancer, 2005, 93 : 1209 - 1214
  • [35] Extremely high level of tumor markers do not worsen outcome of nonseminomatous germ cell tumors (NSGCT) patients with poor prognosis
    Tryakin, A
    Tjulandin, S
    Titov, D
    Zakharova, T
    Figurin, K
    Feinstein, I
    Garin, A
    ANNALS OF ONCOLOGY, 2005, 16 : 292 - 292
  • [36] Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
    Fosså, SD
    Paluchowska, B
    Horwich, A
    Kaiser, G
    de Mulder, PHM
    Koriakine, O
    van Oosterom, AT
    de Prijck, L
    Collette, L
    de Wit, R
    BRITISH JOURNAL OF CANCER, 2005, 93 (11) : 1209 - 1214
  • [37] Results of multimodality therapy in poor risk non-seminomatous germ cell tumors (NSGCT)
    Omuro, Y
    Sasaki, E
    Hayashi, C
    Okamoto, R
    Kobayashi, T
    Maeda, Y
    Sasaki, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 430 - 430
  • [38] Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT).
    Feldman, Darren R.
    Hu, James S.
    Patil, Sujata
    Reuter, Victor E.
    Srinivas, Sandy
    Stadler, Walter Michael
    Costello, Brian Addis
    Milowsky, Matthew I.
    Appleman, Leonard Joseph
    Dorff, Tanya B.
    Bromberg, Maria
    Joseph, Gabriella
    Funt, Samuel Aaron
    Bajorin, Dean F.
    Bosl, George J.
    Quinn, David I.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Accuracy of clinical staging in stage I and IIa/b testicular nonseminomatous germ cell tumors (NSGCT) and implications on survival.
    Srivastava, Arnav
    Patel, Hiren, V
    Kim, Sinae
    Kim, Isaac
    Singer, Eric A.
    Jang, Thomas L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] PROGNOSTIC FACTORS IN METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS
    HANSON, PR
    BELITSKY, P
    MILLARD, OH
    LANNON, SG
    CANADIAN JOURNAL OF SURGERY, 1993, 36 (06) : 537 - 540
12345